These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 15920888)

  • 1. Evaluation of nine strategies for analyzing a cDNA toxicology microarray data set.
    Zhang JJ; Yi T; Zhao LP
    J Biopharm Stat; 2005; 15(3):403-18. PubMed ID: 15920888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statistical approaches in the analysis of gene expression data derived from bone regeneration specific cDNA microarrays.
    Joo J; Ahn H; Lombardo F; Hadjiargyrou M; Zhu W
    J Biopharm Stat; 2004 Aug; 14(3):607-28. PubMed ID: 15468755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Large scale real-time PCR validation on gene expression measurements from two commercial long-oligonucleotide microarrays.
    Wang Y; Barbacioru C; Hyland F; Xiao W; Hunkapiller KL; Blake J; Chan F; Gonzalez C; Zhang L; Samaha RR
    BMC Genomics; 2006 Mar; 7():59. PubMed ID: 16551369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of a data dependent analysis (DDA) yeast cDNA microarray experiment for use in toxicogenomics.
    Mizukami S; Suzuki Y; Kitagawa E; Momose Y; Kim HJ; Iwahashi H
    Environ Sci; 2004; 11(6):325-35. PubMed ID: 15750578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microarray studies of psychostimulant-induced changes in gene expression.
    Yuferov V; Nielsen D; Butelman E; Kreek MJ
    Addict Biol; 2005 Mar; 10(1):101-18. PubMed ID: 15849024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microarray gene expression profiles in dilated and hypertrophic cardiomyopathic end-stage heart failure.
    Hwang JJ; Allen PD; Tseng GC; Lam CW; Fananapazir L; Dzau VJ; Liew CC
    Physiol Genomics; 2002 Jul; 10(1):31-44. PubMed ID: 12118103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Empirical bayes gene screening tool for time-course or dose-response microarray data.
    Eckel JE; Gennings C; Chinchilli VM; Burgoon LD; Zacharewski TR
    J Biopharm Stat; 2004 Aug; 14(3):647-70. PubMed ID: 15468757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and analysis of two-phase experiments for gene expression microarrays-part I.
    Jarrett RG; Ruggiero K
    Biometrics; 2008 Mar; 64(1):208-16. PubMed ID: 17651456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a statistical equivalence test applied to microarray data.
    Qiu J; Cui X
    J Biopharm Stat; 2010 Mar; 20(2):240-66. PubMed ID: 20309757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extrapolating traditional DNA microarray statistics to tiling and protein microarray technologies.
    Royce TE; Rozowsky JS; Luscombe NM; Emanuelsson O; Yu H; Zhu X; Snyder M; Gerstein MB
    Methods Enzymol; 2006; 411():282-311. PubMed ID: 16939796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoregressive-model-based missing value estimation for DNA microarray time series data.
    Choong MK; Charbit M; Yan H
    IEEE Trans Inf Technol Biomed; 2009 Jan; 13(1):131-7. PubMed ID: 19129032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National Oncology Forum: perspectives for the year 2000.
    DeVita VT; Bleickardt EW
    Cancer J; 2001; 7 Suppl 1():S2-13. PubMed ID: 11504281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statistical analysis of DNA microarray data in cancer research.
    Fan J; Ren Y
    Clin Cancer Res; 2006 Aug; 12(15):4469-73. PubMed ID: 16899590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reproducible and reliable microarray results through quality control: good laboratory proficiency and appropriate data analysis practices are essential.
    Shi L; Perkins RG; Fang H; Tong W
    Curr Opin Biotechnol; 2008 Feb; 19(1):10-8. PubMed ID: 18155896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of experimental designs for two-color cDNA microarrays.
    Yang CW; Hsiao CF; Chou CK
    J Comput Biol; 2005 Nov; 12(9):1202-20. PubMed ID: 16305329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and evaluation of Actichip, a thematic microarray for the study of the actin cytoskeleton.
    Muller J; Mehlen A; Vetter G; Yatskou M; Muller A; Chalmel F; Poch O; Friederich E; Vallar L
    BMC Genomics; 2007 Aug; 8():294. PubMed ID: 17727702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microarray analysis of ethanol-induced changes in gene expression.
    Kerns RT; Miles MF
    Methods Mol Biol; 2008; 447():395-410. PubMed ID: 18369932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of normalization techniques for microRNA microarray data.
    Rao Y; Lee Y; Jarjoura D; Ruppert AS; Liu CG; Hsu JC; Hagan JP
    Stat Appl Genet Mol Biol; 2008; 7(1):Article22. PubMed ID: 18673291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of complementary DNA microarray technology to carcinogen identification, toxicology, and drug safety evaluation.
    Afshari CA; Nuwaysir EF; Barrett JC
    Cancer Res; 1999 Oct; 59(19):4759-60. PubMed ID: 10519378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statistical analysis of microarray data: a Bayesian approach.
    Gottardo R; Pannucci JA; Kuske CR; Brettin T
    Biostatistics; 2003 Oct; 4(4):597-620. PubMed ID: 14557114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.